The frequent use of combined products, which involve the joint application of drugs and medical devices, underscores the critical importance of assessing the compatibility between these components. In this insightful webinar, Dr. Lise Vanderkelen and Dr. Ruth Verplaetse will delve into the necessity of ensuring a harmonious relationship between drugs and devices for the ultimate benefit of patient safety and treatment efficacy.
The webinar will provide a comprehensive overview of the various aspects involved in determining the compatibility of combined products. Viewers will learn about the intricate balance required to maintain a healthy interaction between drugs and devices, highlighting the potential risks that can arise from incompatibilities. Ensuring that all these factors are aligned is essential to prevent any adverse effects that could harm patients.
A key focus will be on drug stability when used in conjunction with medical devices. Attendees will learn how to assess and maintain the stability of drugs within combined products, ensuring that the therapeutic efficacy of the drug is not compromised over time. The webinar will also provide detailed guidance on evaluating the chemical compatibility between drugs and device materials. This section will cover the potential chemical interactions that can occur, the methodologies used to test for compatibility, and the implications of these interactions on product safety and performance.
Another critical aspect covered will be the biocompatibility of combined products. Emphasizing the need to ensure that device materials do not induce adverse biological reactions when in contact with the drug or the patient’s body, participants will gain insights into the testing protocols and standards used to verify biocompatibility.
Through passionate discussions and expert insights, Dr. Vanderkelen and Dr. Verplaetse will provide attendees with the knowledge needed to establish and maintain compatibility in combined drug-device products. By the end of this webinar, participants will have a thorough understanding of the critical factors involved in compatibility assessments, enabling them to design and evaluate combined products that are safe, effective, and beneficial for patients.